Marek Brzosko

Marek Brzosko

Pomeranian Medical University - Szczecin / Poland
Medical and Health Sciences / Rheumatology
AD Scientific Index ID: 1799597
Pomorski Uniwersytet Medyczny w Szczecinie
person_outline Marek Brzosko's MOST POPULAR ARTICLES
1-) Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double‐blind treatment phase of a … Arthritis & Rheumatism 63 (3), 609-621, 2011
2-) Three multicenter, randomized, double‐blind, placebo‐controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis Arthritis & Rheumatology 71 (2), 258-270, 2019
3-) Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study Annals of the rheumatic diseases 76 (2), 346-354, 2017
4-) Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double‐blind, placebo‐controlled trials Arthritis & rheumatology 69 (2), 362-375, 2017
5-) The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis Arthritis Res Ther 5, 1-4, 2003